Skip to main content

Post-IPO Equity Health Care Companies

Explore 434 health care startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
434
Total Funding
$921.7M
Avg Funding
$36.9M
Cities
23

Export 434 Post-IPO Equity Health Care Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
New York, United States
$2.0M
raised

Hoth Therapeutics is a clinical-stage biopharmaceutical company focusing on developing new therapies for dermatological disorders.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$1.4M
raised

NewcelX is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ponte Vedra Beach, United States
$2.5M
raised

Cadrenal Therapeutics develops a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Emeryville, United States
$32.5M
raised

Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

Apr 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Farmington, United States
$6.6M
raised

Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.

Apr 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Menlo Park, United States
$40.0M
raised

AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$85.0M
raised

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Bogotá, Colombia
$731K
raised

Blueberries Medical is a producer of medicinal cannabis products.

Mar 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Charlestown, United States
$240.0M
raised

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$6.0M
raised

Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Weston, United States
$2.0M
raised

ZyVersa is committed to improving health outcomes and quality of life for patients with inflammatory and renal diseases.

Mar 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$34.0M
raised

Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.

Mar 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$1.1M
raised

GenFlow Biosciences is a biotech company that develops gene therapies for slow or reverse aging in humans and animals.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Las Vegas, United States
$400K
raised

One World Products is a supplier of hemp and cannabis-derived ingredients for use in the manufacturing of medical, CPGs, and OTC products.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Hollywood, United States
$450K
raised

Healthy Choice Wellness is a holding company focused on providing consumers with healthier daily choices.

Mar 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
$1.8M
raised

Mountain Valley MD Holdings is in the final stages of proving up a low-cost, low-risk exploration project.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Rome, Italy
$2.3M
raised

Cube Labs is the first systematic venture builder in the healthcare technology space in Italy.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Melbourne, Australia
$57.0M
raised

4DMedical is a global medical technology company, revolutionizing respiratory imaging and ventilation analysis for lung diseases.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Louisville, United States
$74.4M
raised

Charlotte's Web develops and distributes hemp-derived cannabidiol wellness products.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Kelowna, Canada
$25.8M
raised

The Valens Company is a biotechnology company focused on extraction and the commercialization of cannabinoid-based consumer products.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$75.0M
raised

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$100.0M
raised

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlsbad, United States
$3.0M
raised

Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Bedford, United States
$125.0M
raised

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Greenwood Village, United States
$2.8M
raised

Applied UV focuses on the development and acquisition of technologies on infection prevention in healthcare, hospitality, and residential.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 226 to 250 of 434 companies

Ready to Connect with Post-IPO Equity Health Care Startups?

Get verified founder emails, funding details, and company data for 434 post-ipo equity health care companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

434 Health Care Post-IPO Equity Startups (September 2026) — Page 10 | VCBacked